Top compounds associated with response to DHCR24


Feature Type Standardized
Nominal ANOVA
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.085 0.02
mRNA tigecycline CTRPv2 pan-cancer AAC -0.13 0.02
mRNA Doxorubicin FIMM pan-cancer AAC -0.33 0.02
mRNA tivozanib GDSC1000 pan-cancer AAC -0.085 0.02
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.09 0.02
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.081 0.02
mRNA CAY10603 GDSC1000 pan-cancer AAC -0.074 0.02
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.087 0.03
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.03
mRNA SGC0946 GDSC1000 pan-cancer AAC -0.085 0.03
Download CSV